Drugs / secoisolariciresinol diglucoside
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01276704 | Jan 2011 → Jul 2017 | breast cancer | Carol Fabian, MD | Terminated | Missed primary Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | secoisolariciresinol diglucoside | “We conducted a multiinstitutional, placebo-controlled phase IIB trial of the lignan secoisolariciresinol diglucoside (SDG) found in flaxseed.” PMID 32312713 ↗ Apr 2020 |
| Known as | Brevail | “12 months of SDG (Brevail) vs placebo” NCT01276704 ↗ |
| Modality | Small molecule | — CHEMBL2391148 ↗ |